Roncali et al. demonstrated that a tumour rechallenge in the hemisphere not exposed to TAT elicited immune memory, indicating the establishment of an anti-tumour immune response following locoregional treatment targeting SDC1 63. Here, SDC1 is linked to neoplasm.